Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGT| |AGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCT
End
84367370/85071552 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/2231328; hsa-mir-103a-1/Downstream/2043327;
Upstream sequence
gtagatgataatagtgcatatgccatgtgattgtgatgagtaaatgatgtacctgcatgtaaactgtttatcacagtgcctgacacatatgctcaataca
Downstream sequence
GACAATATCTGAGACTCAAAAAGCTCTGCATTCTATTTCCCTATTCCTATTATTCCCACCTTAAGTGTAAGGAATCCATAAGAAAATAAGTCTACAATTT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.